Melanoma

Showing NaN - NaN of 70

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Melanoma Trial in Australia, United States (PV-10, Pembrolizumab)

Recruiting
  • Melanoma
  • Los Angeles, California
  • +6 more
Mar 22, 2022

Melanoma, NSCLC, Brain Metastasis Trial in New Haven, Tampa (Pembrolizumab plus Bevacizumab)

Recruiting
  • Melanoma
  • +2 more
  • Pembrolizumab plus Bevacizumab
  • New Haven, Connecticut
  • +1 more
Feb 18, 2022

Melanoma, Advanced Non Small Cell Lung Cancer Trial in United Kingdom, United States (Long-Term Follow-Up of Patients who

Not yet recruiting
  • Melanoma
  • Advanced Non Small Cell Lung Cancer
  • Long-Term Follow-Up of Patients who Received ATL001
  • Tampa, Florida
  • +9 more
Feb 15, 2022

Melanoma Trial in United States (MGA271)

Terminated
  • Melanoma
  • MGA271
  • Los Angeles, California
  • +6 more
Feb 4, 2022

Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

Completed
  • Prostate Cancer
  • +6 more
  • MGA271
  • Los Angeles, California
  • +11 more
Feb 4, 2022

Melanoma Trial in United States (Ipilimumab, Nivolumab)

Completed
  • Melanoma
  • Duarte, California
  • +35 more
Sep 8, 2021

Melanoma, Head Neck Cancer, Non Small Cell Lung Cancer Trial in United States (Enoblituzumab, Pembrolizumab, MGA012)

Completed
  • Melanoma
  • +3 more
  • Enoblituzumab
  • +2 more
  • Scottsdale, Arizona
  • +19 more
Sep 22, 2021

Melanoma Trial in Worldwide (nivolumab, ipilimumab)

Completed
  • Melanoma
  • nivolumab
  • ipilimumab
  • Tucson, Arizona
  • +123 more
Aug 24, 2021

Melanoma, Unresectable (Stage III) Melanoma, Metastatic (Stage IV) Melanoma Trial in United States (Omaveloxolone Capsules (2.5

Completed
  • Melanoma
  • +2 more
  • Omaveloxolone Capsules (2.5 mg/capsule)
  • +4 more
  • Mobile, Alabama
  • +9 more
Jun 4, 2021

Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)

Active, not recruiting
  • Metastatic Cancer
  • +4 more
  • VE800
  • +2 more
  • Scottsdale, Arizona
  • +17 more
Jun 22, 2021

Melanoma Trial in Worldwide (Nivolumab, Ipilimumab)

Withdrawn
  • Melanoma
  • Nivolumab
  • Ipilimumab
  • Gilbert, Arizona
  • +117 more
Mar 17, 2021

Melanoma Trial in Worldwide (Dabrafenib, Trametinib, Trametinib )

Completed
  • Melanoma
  • Scottsdale, Arizona
  • +120 more
Feb 8, 2021

Biomarkers in Subjects With Untreated Melanoma

Terminated
  • Melanoma
  • Blood Sample Collection
  • Little Rock, Arkansas
  • +35 more
Feb 9, 2021

Breast Cancer, NSCLC, Melanoma Trial in Worldwide (Abemaciclib)

Completed
  • Breast Cancer
  • +3 more
  • Duarte, California
  • +43 more
Dec 17, 2020

Melanoma Trial in Worldwide (Immunotherapeutic GSK2132231A)

Completed
  • Melanoma
  • Immunotherapeutic GSK2132231A
  • Los Angeles, California
  • +62 more
Dec 7, 2020

Sarcoma, Melanoma, NSCLC Trial in United States (CMB305, G100, Metronomic CPA)

Terminated
  • Sarcoma
  • +3 more
  • CMB305
  • +2 more
  • Santa Monica, California
  • +7 more
Jun 29, 2020

Melanoma, Tumor Trial in Tampa (Karenitecin (BNP1350))

Completed
  • Melanoma
  • Neoplasm
  • Karenitecin (BNP1350)
  • Tampa, Florida
    For Information call 210-614-1701 for a site near you
Mar 10, 2020

Melanoma Trial in Tampa (MAGE-A3 ASCI injections without Poly IC:LC, MAGE-A3 ASCI injections with Poly IC:LC)

Terminated
  • Melanoma
  • MAGE-A3 ASCI injections without Poly IC:LC
  • MAGE-A3 ASCI injections with Poly IC:LC
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 18, 2019

Melanoma Trial in Canada, United States (Talimogene laherparepvec)

Completed
  • Melanoma
  • Talimogene laherparepvec
  • Tampa, Florida
  • +13 more
Nov 6, 2019

Tumors, Melanoma, Colorectal Tumor Trial in United States (ASN003 ascending doses, ASN003 MTD)

Terminated
  • Neoplasms
  • +3 more
  • ASN003 ascending doses
  • ASN003 MTD
  • Los Angeles, California
  • +4 more
May 17, 2019

Melanoma Trial in United States (Epacadostat, Placebo, ipilimumab)

Terminated
  • Melanoma
  • Los Angeles, California
  • +6 more
Mar 19, 2019

Mucosal Lentiginous Melanoma, Acral Melanoma, Melanoma Trial in United States (Nilotinib)

Completed
  • Mucosal Lentiginous Melanoma
  • +2 more
  • Santa Monica, California
  • +7 more
Oct 16, 2018

Renal Cell Carcinoma, Melanoma, Lung Cancer Trial in United States (Infliximab + Prednisone, Methylprednisolone + Prednisone)

Withdrawn
  • Renal Cell Carcinoma
  • +2 more
  • Infliximab + Prednisone
  • Methylprednisolone + Prednisone
  • Los Angeles, California
  • +9 more
Oct 5, 2018

Compare Quality of Life and Compliance in Patients Receiving

Unknown status
  • Melanoma
    • Tampa, Florida
    • +3 more
    Apr 17, 2018

    Melanoma Trial in United States (Minimally invasive inguinal lymph node dissection)

    Completed
    • Melanoma
    • Minimally invasive inguinal lymph node dissection
    • Scottsdale, Arizona
    • +10 more
    Mar 21, 2018